← SynDRA
MK-3697
SynDRA canonical compound SYN0044593 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HCRTR2 |
|---|
| Mechanism of action | orexin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- HCRTR1 ANTAGONIST
- HCRTR2 ANTAGONIST
- orexin receptor antagonist
Cross-references
Synonyms
- CHEMBL3338865
- M8238285OA
- RefChem:159202
- MFCD22572350
- MK3697
- VSOUDUXMPUHJEU-UHFFFAOYSA-N
- GTPL9307
- orb1307127
- SCHEMBL2250597
- SCHEMBL29766792
- UNII-M8238285OA
- EX-A946
- BDBM106971
- GLXC-90202
- AKOS026750261
- CS-3376
- EBC-520392
- compound 24 [PMID: 25248679]
- NCGC00387851-04
- AC-36057
- AS-17000
- HY-12301
- M403007
- US8592457, 7-5
- BRD-K95828359-001-01-0
- N-[(5,6-Dimethoxy-2-pyridinyl)methyl]-5'-methyl-5-(2-thiazolyl)-[2,3'-bipyridine]-4-carboxamide
Look up MK-3697 in the interactive SynDRA portal →